Diego and Lola, the philanthropists of Spanish researchers, AEF award.
Diego Megía and Lola Manterola, a cancer patient, are co-founders of CRIS Cancer Foundation and have been awarded a Philanthropic Initiative award in the seventh edition of the Awards of the Spanish Association of Foundations (AEF). This award recognises the work of the founders of CRIS Cancer Foundation, which was born almost 12 years ago
PROGRESS REPORT ON PROJECTS AND PROGRAMMES 2022:
National Projects: CRIS Haematological Tumours Unit They have participated in an international clinical trial for a type of immunotherapy (teclistamab) that has seen improvements in more than 70% of myeloma patients. These great results suggest that this therapy should be approved for clinical practice very soon. They have identified a mechanism whereby tumour cells from
CRIS Cancer attacks metastatic prostate cancer comprehensively using the most advanced molecular analysis tools
• The projects supported by CRIS Cancer combine research and patient care, together with advanced techniques of genetic analysis, computational immunology and artificial intelligence. All in order to predict the progress of patients and treat them in a more personalized way. • CRIS Cancer finances the CRIS Prostate Cancer Unit, as well as 5 new
CRIS Cancer delivers the CRIS Programs to 17 outstanding researchers with an endowment of 11 million euros for 5 years
CRIS Cancer identifies after a thorough process 17 outstanding researchers, 10 women and 7 men, to develop better therapies for patients with cancer of the colon, prostate, acute myeloid leukemia, hematological tumors, lung, breast, follicular lymphoma, ovary, and melanoma. ● The winning projects in the three different categories are carried out in 12 research centers
CRIS Support a strategy designed to identify therapeutic targets in triple negative breast cancer
• A new strategy has been developed to make it possible to identify tumor cell membrane proteins, in order to later specifically attack these cells using specific antibodies against these proteins. • This work lays the groundwork for defining new potential targets of drug-conjugated antibodies in other solid or hematological tumors. • The research has
CRIS Cancer announce new Unit for New Experimental Therapies
The CRIS Cancer Foundation, non-profit organization promoting research against cancer, is thrilled to announce that San Carlos Clinical Hospital will inaugurate CRIS Unit for New Experimental Therapies financed by CRIS Cancer. On Tuesday, March 29 at 11:00 a.m., the CRIS Unit for New Experimental Therapies financed by CRIS Cancer will be officially inaugurated at the
‘A Night to Remember’ – our 10th anniversary celebration ball
CRIS Cancer Foundation began as a dream 10 years ago for a small group of us. Today we are humbled, proud and grateful to see how that mission is shared by a community of over 55,000 people, including our 50,000 monthly donors! For 10 years, we’ve been funding research projects, providing grants and fellowship programmes
Be a CRIS GEM
A GEM. That is what you are to CRIS. An incredible person willing to take action and work with us to achieve a world free of cancer. Join our new membership club, CRIS GEMs, and Give Every Month to support life-saving cancer research. “I was diagnosed with lung cancer and told I would end up being tetraplegic. But I was lucky and got
CRIS Virtual Fundraising Gala 2020 – A Time for Research
The CRIS 2020 virtual gala: ”A Time For Research” Our biggest fundraising event went virtual in 2020, raising over £770,000 to fund vital research into cancer treatments. Every year, our annual fundraising ball raises an incredible amount of money for cancer research. But with social distancing guidelines in place, a ball with 400 guests in one venue was impossible. So, in 2020, we decided to bring the ball to our guests, using a virtual event platform. On Saturday 7
Annual Ball 2019: A Night to Unite
We are delighted that our Annual Ball, A Night to Unite, was an outstanding success! With your generous support we approximately raised £800,000 (with potential Gift Aid). Thanks to your immense generosity we are able to keep working towards supporting cutting edge research and making progress that saves more lives. We would like to take this opportunity to extend our special appreciation to RJ O’Brien for
My SuperCRIS Challenge
What is My SuperCRIS Challenge? My SuperCRIS challenge is for everyone, any age and any gender. We all work as one to raise money and awareness and raise money for cancer research so together, we can end cancer. The idea is to challenge yourself by taking part in fun and exciting challenges and raising money
Garrett’s Head South Challenge for CRIS
This Christmas, we have an exciting campaign with a very special purpose! HERE is a fantastic opportunity to give the gift of hope to children with brain tumours. HOW? One of our patrons, Garrett Curran, is walking to the South Pole with the Lewis Moody Foundation as part of the Headsouth Challenge to raise funds
Meet dr Vivian Dimou
Dr Vivan Dimou is a Postdoctoral Training Fellow in the Cancer Immunotherapy team, led by Dr Astero Klampatsa at The Institute of Cancer Research (ICR). This research team was generously funded by CRIS Cancer Foundation. Vivian is working on novel immunotherapeutic approaches in mesothelioma – a rare and aggressive type of cancer arising primarily in
CRIS bladder cancer study among the top four in the world.
A promising study of bladder cancer supported by CRIS Cancer Foundation has been selected as one of the top four worldwide for its quality and relevance by the American Society for Clinical Oncology (ASCO). This wonderful news was received even as Dr. Enrique Grande, Chief of Medical Oncology at MD Anderson Cancer Centre, Madrid, made a presentation at the 1st Congress of ASCO, the world´s most recognised oncology event. “Professionally, within oncology, it is
Skin Cancer Awareness
By Cecilia Linares During the past 6 weeks we have been enjoying beautiful weather in the UK. It has made us all very happy during lockdown. Staying at home has contributed to decreased stress levels in some aspects. We are eating slowly, homemade food and sun tanning some more. All good news for healthy
Isolation Story: We Will Get Through It
Eduardo tells us his family’s story of isolation during his son’s cancer treatment and the impact of it on them. WIFI, Netflix, Amazon Prime, HBO, you have all the entertainment in the world, all the social networks, all the advantages of being at home and with your family. The comfort of sleeping in your
CRIS researchers discover new therapy to treat one of the most aggressive breast cancers.
Advance published in the journal EMBO Molecular Medicine: The demonstration that an antibody conjugated to a drug, called EV20/MMAF, is effective against HER2-positive breast tumours that have become resistant to different anti-HER2 therapies. The CRIS research group for breast and ovarian cancer, which CRIS Cancer Foundation has been funding for 7 years, has made a new
Immunotherapy in the coronavirus era
By Jesús Sanchez Ruiz PhD, CRIS Project Manager Immunotherapy has now become a familiar term in any conversation about cancer therapy. In fact, it is one of the lines of research that CRIS has been supporting over a few years in different Units, based in Madrid in the University Hospital 12 de Octubre, the
Stimulating the immune system
Is it really possible to strengthen my immune system? We live in a unique situation these days with social distancing and home confinement increasing our levels of stress and worry. The quality of our sleep is affected, our levels of exercise has decreased and making healthy choices becomes a more complicated task. All this contributes to reducing our natural defences at a time when they are particularly relevant. Cancer patients are especially vulnerable as both disease and
The 2.6 Challenge
The 2.6 Challenge is a simple and fun way for everyone to do their bit to help fund cancer research during this crisis. Thousands of cancer diagnoses are being missed each week. Cancer wont stop during the COVID-19 outbreak and neither will we. Investment in medical research is needed more than ever. Sign
CRIS Project Update. Improved treatment for babies with brain tumours
In the UK, CRIS has been funding the childhood brain cancer project at the Institute of Cancer Research (ICR), coordinated by Prof. Chris Jones, since 2015. Now, the ICR team has announced a breakthrough which will change treatment for babies with brain tumours. This team of scientists carried out a large-scale study of 241 infants from around the world diagnosed with glioma
A CRIS supported investigation into the immune system of immunodeficient and cancer patients infected with COVID-19.
The unprecedented health emergency that we are experiencing in the UK and throughout the world requires a response that is unprecedented. Right now, it is urgent to develop new therapeutic strategies to contain the pandemic and also assist those who are more vulnerable to the disease, such as cancer patients. In order
Leading trials against coronavirus
Joaquín Martínez, Head of the CRIS Unit for Haematological Tumours participates in two leading trials against coronavirus. CRIS Cancer Foundation knows how vital research is to make advances to cure diseases and so is supporting two clinical trials in the fight against coronavirus. We do so by making available the use of the CRIS Haematology Tumour Unit at 12 October University Hospital,
CRIS and COVID-19
At CRIS, our mission is to beat cancer and achieve a total cure through the funding of much-needed cancer research. We have always had the conviction that the only way to beat cancer is through funding scientific research – ‘Investing in research is investing in life’. This truth is now echoed by others in the current
Cancer and COVID-19
Six cancer patients show us how to live with the current ‘anti Coronavirus’ measures that are in place and tell us why it is important to continue scientific research. Due to the fragility of their immune system caused by chemotherapy or radiotherapy, cancer patients are used to the measures implemented and are confident: “Together we will overcome it.” “In research, we give life to patients with Coronavirus, cancer and
CRIS & COVID-19. Message from our President Lola Manterola
Dear CRIS supporters! To those who don’t know me, I am Lola Manterola, President of CRIS Cancer Foundation and I have cancer. I have been in isolation with my family for the last two weeks. Yet, even isolated, we feel closer than ever with our friends, extended family, our community. We all care about each
Triple the impact! Garrett Currant raises over £125,000 for brain tumour research
Intrepid adventurer Garrett recently returned from the furthest reaches of the South Pole, where he joined the Headsouth Challenge team on an incredible sponsored expedition. Together, they braved extreme weather conditions, severe altitude sickness and many more challenges to raise much-needed funds for cancer research. Here’s Garrett’s story. As the rest of the UK
Be one more volunteer
Our wonderful CRIS volunteers help us fund the incredible life-saving research projects that are making such a difference in the fight against cancer. To make World Cancer Day, we wanted to share with you just some of their stories. Will you join them, and be one more? That’s why 95% of the money
Transforming cancer treatment, one more step at a time
This World Cancer Day, find out more about how our research projects are revolutionising cancer therapies and saving lives. Here at CRIS, we know that investing in research is the only way we can hope to beat cancer. That’s why 95% of the money we raise goes straight into projects across the UK
Be One More
This World Cancer Day, we’re asking you to pledge your support and join us in our fight against cancer. From making a regular or one-off donation to arranging a fundraising event, there are lots of ways you can help. Will you raise your hand and be one more? At CRIS, an incredible 95% of
The Future of Research: Immunotherapy
Paul Workman, president and CEO of the Institute of Cancer Research in London: “The world for cancer patients will be very different over the next 20 years thanks to immunotherapy”. CRIS Cancer Foundation operates in three countries: Spain, France and the United Kingdom. Each entity operates autonomously, but we all work together with a
The first child treated with CAR-T cell therapy has been discharged from the CRIS Unit for Research and Advanced Therapies in Childhood Cancer, funded by the CRIS Cancer Foundation at the Hospital de La Paz
After just one year in operation, the CRIS Unit for Research and Advanced Therapies in childhood cancer based at Madrid’s Hospital de la Paz has shown that immunotherapy treatments using CAR-T cells are effective in children with certain types of leukaemia who do not respond to conventional treatments. For this reason, the CRIS Cancer Foundation
ICR celebrates major donation from CRIS Cancer Foundation
At ICR Discovery Club event, members thanked CRIS Cancer Foundation for the donation of £1.4 million made to support immunotherapy research at the ICR. A cheque for £1.4 million was presented by the founders of the CRIS Cancer Foundation, Lola Manterola and Diego Megia, to help fund immunotherapy research at the ICR. New team
SECOND HAND SALE
We are delighted to share that yesterday´s CRIS Cancer Second Hand Sale was an outstanding success! Thanks to your immense generosity we have been able to raise an incredible £2.700 net. This amount will go directly towards the research projects CRIS is funding at the ICR London: Children with Brain Tumour and Immunotherapy Projects. THIS WOULD NOT HAVE BEEN POSSIBLE WITHOUT YOUR
Brain Tumour in Children Project. New treatments for diffuse midline gliomas
A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG) Diffuse midline glioma is a type of primary, high-grade brain tumour that occurs in children. It is one of the most fatal paediatric brain tumours, with
CRIS Cancer has become ANANAYS chosen charity
With every purchase, ananays donates a 5% to CRIS Cancer Foundation to fight against Cancer. Let’s fight together. You buy, You care, You cure. Ananays brings together fresh and exciting brands with an exotic and Mediterranean feel. These stylish sophisticated and cool brands from far flung destinations will give your getaway wardrobe an individual
Cancer Immunotherapy
Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are
You’ll never walk alone
This Champions League final is setting out to be the most charitable in recent years. Fans of both teams have joined the CRIS Cancer Foundation to support cancer research, the only path available to the 40% of cancer cases that are currently incurable. The supporters’ clubs North Fans (R. Madrid) and Madrid Reds (Liverpool), plus physicians, CRIS investigators
The new CRIS Immuno-Oncology Unit
The new CRIS Immuno-Oncology Unit, to be developed at Hospital 12 de Octubre, financed by CRIS Cancer, will focus on one of the most promising strategies to beat cancer: immunotherapy. This Unit is the first integrated programme dedicated to preclinical and clinical research for cancer immunotherapy in Spain. Reputed oncologists, haematologists, immunologists and molecular
CRIS finances the first Integrated Immuno-Oncology Unit at Hospital 12 de Octubre
CRIS has donated 2.5 million Euro to start-up this unique, multidisciplinary and innovative program dedicated to preclinical and clinical research in cancer immunotherapy in Spain, and continues financially supporting the HUNET- CRIS Unit at University Hospital 12 de Octubre, a pioneering unit in early-stage trials for blood cancers. “The future of cancer research
Cancer Immnunotherapy
Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are adept at
Gabi Clinical Trial
1. Objective: The Gabi Clinical Trial aims to find a novel therapeutic alternative for children who suffer from solid or haematological tumours and are in relapse, or have no other treatment alternatives. This treatment seeks to provide the patient with reinforcements to its immune system, enhanced with state-of-the-art techniques, so that the patient may reject
Cris Team started this initiative two years ago and the results were outstanding. In 2016 and 2017, 73 fundraisers like you, raised a total amount of £135,459, to invest in cancer research!. Would you like to be one of our heroes? Challenge yourself and raise money by completing your chosen challenge. Join us today! What
Three CRIS Fellowships to investigate in international centres of excellence
CRIS has awarded three fellowships to cutting-edge projects in international centres of excellence, within the framework of the CRIS SEOR fellowship scheme with a value of 70,000 Euro. In Spain, only 0.92 Euro per capita is invested in cancer research, ranking close to the bottom of the list of peer countries. CRIS Cancer Foundation, in
World Cancer Day 2017
CRIS CANCER FOUNDATION invites you to join us with your colleagues and friends to celebrate WORLD CANCER DAY and the launch of MY SUPERCRIS CHALLENGE 2017 TUESDAY – FEBRUARY 7, 2017 Drinks&Tapas: 6:30pm 8:30pm HISPANIA 72-74 LOMBARD STREET LONDON EC3V 9AY RSVP BY: 3th February here. All Together in the fight against cancer SPONSORED BY:
What a Night it was!
Cris cancer celebrated it’s 5th annual gala bringing together friends and patrons to celebrate another successful year of fundraising and helping in the fight against cancer. The night was a celebration of not just the survivors but of everyone whose lives are even remotely affected by this deadly disease. The nurses, the doctors, the scientist,